927 results on '"Palmer, James N"'
Search Results
2. Frailty does not worsen postoperative outcomes in sinonasal squamous cell carcinoma
- Author
-
Kshirsagar, Rijul S., Eide, Jacob G., Qatanani, Anas, Harris, Jacob, Birkenbeuel, Jack L., Wang, Beverly Y., Kuan, Edward C., Palmer, James N., and Adappa, Nithin D.
- Published
- 2023
- Full Text
- View/download PDF
3. Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy
- Author
-
Chao, Tiffany N, Kuan, Edward C, Tong, Charles CL, Kohanski, Michael A, Grady, M Sean, Palmer, James N, Adappa, Nithin D, and O'Malley, Bert W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Immunology ,Vaccine Related ,Immunization ,Clinical Research ,Cancer ,Patient Safety ,Evaluation of treatments and therapeutic interventions ,6.4 Surgery ,mucosal melanoma ,sinonasal malignancy ,endoscopic skull base surgery ,immunotherapy ,Neurology & Neurosurgery ,Dentistry - Abstract
Objective Surgical resection is widely accepted as a critical component for definitive treatment of sinonasal mucosal melanoma. Systemic immunotherapy, including multiple newer agents, has been used to treat metastatic or unresectable disease. In this study, we examine its efficacy in locoregional control when used in conjunction with surgical resection for primary mucosal lesions. Design Present study is a retrospective review of all patients at a tertiary academic medical center with primary sinonasal mucosal melanoma and distant metastatic disease. Results A total of four patients were identified. In all cases, patients were treated with a combination of surgical resection of the primary tumor and systemic immunotherapy. Three patients were initially treated with surgery at the primary site followed by immunotherapy for distant metastases. Response to immunotherapy at the sites of primary and metastatic disease was seen in two patients. All four patients developed progression or recurrence at the primary site following initiation of immunotherapy for which they underwent surgical resection. One patient remains in follow-up without evidence of disease 20 months after initial treatment; three succumbed to the disease at 135, 37, and 16 months after initial treatment. Conclusion Surgical resection for local control plays a critically important role in the treatment of sinonasal mucosal melanoma regardless of the presence of metastases and whether immunotherapy will be given. This case series suggests that, though immunotherapy may demonstrate efficacy in managing distant disease, surgery should remain the first-line treatment for the primary site.
- Published
- 2021
4. Factors Associated with and Temporal Trends in the Use of Radiation Therapy for the Treatment of Pituitary Adenoma in the National Cancer Database
- Author
-
Fathy, Ramie, Kuan, Edward, Lee, John YK, Grady, M Sean, Alonso-Basanta, Michelle, Palmer, James N, Adappa, Nithin D, O'Malley, Bert W, and Brant, Jason
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Clinical Research ,radiation therapy ,pituitary adenoma ,national cancer database ,temporal trends ,radiation ,watchful waiting ,skull base ,anterior skull base ,Neurology & Neurosurgery ,Dentistry - Abstract
Objective Radiation therapy represents an uncommon but important component of treatment plans for some pituitary adenomas (PAs). Although radiation therapy has been used to treat pituitary adenomas for over a century, general trends in the usage of radiation therapy for this purpose have not been reviewed. Additionally, there are few large studies evaluating how radiation therapy is used for the treatment of these benign tumors. Investigating these trends and identifying any variations in radiation therapy utilization would help to better inform treatment decisions and improve patient outcomes. Design Present study is a retrospective analysis of cases using the National Cancer Database. Setting The research was organized at a tertiary academic medical center. Participants Patients were diagnosed with pituitary adenoma between 2004 and 2014 within the National Cancer Database (NCDB). Methods Temporal trends in the usage of radiation therapy to treat pituitary adenoma were analyzed through a retrospective analysis of 77,142 pituitary adenoma cases from the NCDB between 2004 and 2014. Univariate and multivariate analyses were to examine the relationship between patient, tumor, and treatment factors, and the incorporation of radiation therapy into the treatment of pituitary adenomas. We adjusted for potential confounders such as age, sex, race, comorbidity score, facility type, and year of diagnosis. Results A total of 77,142 patients met inclusion criteria. Inclusion of radiation therapy in pituitary adenoma treatment was 8.0% in 2004 and steadily declined to a low of 3.1% in 2014. Overall, patients were less likely to receive radiation for their pituitary adenoma over time ( p
- Published
- 2021
5. Adenocarcinoma of the Sinonasal Tract: A Review of the National Cancer Database
- Author
-
Patel, Neil N, Maina, Ivy W, Kuan, Edward C, Triantafillou, Vasiliki, Trope, Michal A, Carey, Ryan M, Workman, Alan D, Tong, Charles C, Kohanski, Michael A, Palmer, James N, Adappa, Nithin D, Newman, Jason G, and Brant, Jason A
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Rare Diseases ,Clinical Research ,Cancer ,National Cancer Database ,sinonasal adenocarcinoma ,skull base ,cranial base ,nose and paranasal sinuses ,outcomes ,cost-effectiveness ,outcomes/cost-effectiveness ,Neurology & Neurosurgery ,Dentistry - Abstract
Background Sinonasal adenocarcinoma (SNAC) is a rare malignancy arising from mucus-secreting glandular tissue. Limited large-scale studies are available due to its rarity. We evaluated SNAC in the National Cancer Database (NCDB), a source that affords multi-institutional, population studies of rare cancers and their outcomes. Methods The NCDB was queried for adenocarcinoma in the sinonasal tract. Multivariate analyses were performed to evaluate for factors contributing to overall survival (OS). Results A total of 553 patients were identified. The cohort was composed of 59.3% males. The nasal cavity was the most common primary site, representing 44.1% of cases. About 5.7% of patients presented with nodal disease, while 3.3% had distant metastases. About 40.6% of cases presented with stage IV disease. About 73.5% of patients underwent surgery, 54.2% received radiation therapy, and 27.7% had chemotherapy. Median OS was 71.7 months, while OS at 1, 2, and 5 years was 82, 73.0, and 52%, respectively. On multivariate analysis, advanced age (hazard ratio [HR]: 1.04; 95% confidence interval [CI]: 1.02-1.05), Charlson-Deyo score of 1 (HR: 1.99; 95% CI: 1.20-3.30), advanced tumor grade (HR: 2.73; 95% CI: 1.39-5.34), and advanced tumor stage (HR: 2.71; 95% CI: 1.33-5.50) were associated with worse OS, whereas surgery (HR: 0.34; 95% CI: 0.20-0.60) and radiation therapy (HR: 0.55; 95% CI: 0.33-0.91), but not chemotherapy (HR: 1.16; 95% CI: 0.66-2.05), predicted improved OS. Conclusions SNAC is a rare malignancy with 5-year survival approximating 50%. Surgery and radiation therapy, but not chemotherapy, are associated with improved survival, and likely play a critical role in the interdisciplinary management of SNAC.
- Published
- 2020
6. Image guided dilation of sinus ostium in revision sinus surgery
- Author
-
Han, Joseph K., Palmer, James N., Adappa, Nithin D., Nachlas, Nathan E., Chandra, Rakesh K., Jacobs, Joseph B., Manes, R. Peter, and McKenzie, Karen
- Published
- 2023
- Full Text
- View/download PDF
7. Disorders Involving a Persistent Craniopharyngeal Canal: A Case Series
- Author
-
Poonia, Seerat K, Cazzador, Diego, Kaufman, Adam C, Kohanski, Michael A, Kuan, Edward C, Tong, Charles CL, Carlson, Roy D, Borsetto, Daniele, Emanuelli, Enzo, Palmer, James N, and Adappa, Nithin D
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Patient Safety ,craniopharyngeal canal ,congenital ,endoscopic ,skull base ,surgery ,cerebrospinal fluid ,Neurology & Neurosurgery ,Dentistry - Abstract
Objectives A persistent craniopharyngeal canal (CPC) is a rare embryologic remnant that presents as a well-corticated defect of the midline sphenoid body extending from the sellar floor to the nasopharynx. Our case series aims to describe three unique presentations of this congenital anomaly and their subsequent management. Design Retrospective review. Setting Tertiary academic medical center. Participants Patients who underwent endoscopic transnasal surgical repair of a CPC lesion. Main Outcome Measures Resolution of symptoms and surgical outcomes. Results A total of three patients were identified. The clinical presentation varied, however, all cases prompted further imaging which demonstrated a persistent CPC and associated pathologic lesion. The presentation of a persistent CPC with nasal obstruction and subsequent iatrogenic cerebrospinal fluid leak as in Case 1 demonstrates the importance of imaging in this work-up. Cases 2 and 3 in the series were representative of the larger subset of patients in the literature who present with the defect incidentally but still warrant surgical management. Nonetheless, a standard approach to diagnosis with preoperative imaging and subsequent transnasal endoscopic repair of the skull base defect was undertaken. Conclusion The persistent CPC is a rare congenital anomaly associated with diverse pathology and careful review of preoperative radiology is critical to the management. When warranted, subsequent surgical repair and reconstruction is associated with excellent postoperative outcomes.
- Published
- 2020
8. Smell Preservation following Unilateral Endoscopic Transnasal Approach to Resection of Olfactory Groove Meningioma: A Multi-institutional Experience
- Author
-
Orgain, Carolyn A, Kuan, Edward C, Alvarado, Raquel, Adappa, Nithin D, Jonker, Benjamin P, Lee, John YK, Palmer, James N, Winder, Mark, and Harvey, Richard J
- Subjects
Neurosciences ,Clinical Research ,Rare Diseases ,endoscopic ,skull base ,surgery ,olfactory groove meningioma ,smell ,smell preservation ,Neurology & Neurosurgery - Abstract
Introduction Olfactory groove meningiomas (OGMs) are often associated with loss of smell following resection. Loss of smell has a measurable impact on quality of life. Smell preservation has been previously described in open approaches for early stage or unilateral OGMs. Evidence of smell preservation in endoscopic approaches is lacking. Design A multi-institutional retrospective review was performed on consecutive patients who underwent unilateral endoscopic endonasal resection of OGM. A gross total resection was achieved with preservation of the contralateral olfactory cleft and bulb. Olfactory function was assessed with a six-point olfactory symptom score and the Sniffin' Sticks 12-item smell identification test (SS-12). Contralateral olfactory bulb volume was measured on postoperative magnetic resonance imaging. Results Four patients (age 42.0 ± 7.5, 75% female) were assessed. Olfactory function was assessed at 21.8 ± 5.6 months following surgery. All patients reported some degree of smell preservation (75% described a slight/mild impairment in smell or better). Olfactory identification was preserved with an SS-12 score of 9 ± 1.4 (anosmia defined as ≤6). The olfactory bulb volume was calculated to be 47.4 ± 15.9 mm 3 (normal >40 mm 3 ). Conclusion Smell preservation is possible following unilateral endoscopic endonasal resection of carefully selected OGM.
- Published
- 2020
9. A Population-Level Analysis of Pituitary Carcinoma from the National Cancer Database
- Author
-
Carey, Ryan M, Kuan, Edward C, Workman, Alan D, Patel, Neil N, Kohanski, Michael A, Tong, Charles CL, Chen, Jinbo, Palmer, James N, Adappa, Nithin D, and Brant, Jason A
- Subjects
Clinical Research ,Clinical Trials and Supportive Activities ,Rare Diseases ,Human Genome ,Genetics ,Cancer ,Evaluation of treatments and therapeutic interventions ,6.4 Surgery ,Good Health and Well Being ,pituitary carcinoma ,National Cancer Database ,overall survival ,pituitary ,skull base ,outcomes ,Neurology & Neurosurgery - Abstract
Objectives Pituitary carcinoma is a rare entity with fewer than 200 total cases reported in the English literature. Analysis of the population-level data from the National Cancer Database (NCDB) affords the opportunity to study this poorly understood tumor type. Methods The NCDB was queried for site, histology, and metastasis codes corresponding to pituitary carcinoma. Statistical analyses were performed to determine factors associated with overall survival (OS). Results A total of 92 patients with pituitary carcinoma met inclusion criteria. The 1 and 5 years of OS for all patients was 93.3% (95% confidence interval [CI]: 88.2-98.6%) and 80.0% (95% CI: 71.6-89.4%), respectively. Patients with invasive primary tumor behavior had 1 and 5 years of OS of 69.2% (95% CI: 48.2-99.5%) and 52.7% (95% CI: 31.2-89.2%), respectively. Multivariate analysis demonstrated that compared with benign primary behavior, invasive behavior had increased all-cause mortality (hazard ratio [HR], 1,296, 95% CI: 15.1- > 2,000). Surgery without adjuvant radiation or chemotherapy was the most common therapy (48.9%), followed by no treatment (40.2%). Compared with surgery alone, no treatment had worse OS (HR, 11.83, 95% CI: 1.41-99.56). Increasing age and female sex were both associated with increased mortality. Conclusions The most common treatment for pituitary carcinoma is surgery alone followed by no surgery. Surgery alone has significantly better OS compared with no treatment. The efficacy of radiation, chemotherapy, and neurohormonal treatments needs to be examined with prospective studies.
- Published
- 2020
10. Reconstruction with Mucosal Graft Reduces Recurrence After Endoscopic Surgery of Rathke Cleft Cyst
- Author
-
Eide, Jacob G., Salmon, Mandy K., Kshirsagar, Rijul S., Patel, Tapan D., Davin, Kathleen M., Prasad, Aman, Stevens, Elizabeth M., Ungerer, Heather, Sweis, Auddie M., Locke, Tran B., Lee, John Y., Grady, M. Sean, Yoshor, Daniel, Storm, Phillip B., Adappa, Nithin D., and Palmer, James N.
- Published
- 2022
- Full Text
- View/download PDF
11. Fungal extracts stimulate solitary chemosensory cell expansion in noninvasive fungal rhinosinusitis.
- Author
-
Patel, Neil N, Triantafillou, Vasiliki, Maina, Ivy W, Workman, Alan D, Tong, Charles CL, Kuan, Edward C, Papagiannopoulos, Peter, Bosso, John V, Adappa, Nithin D, Palmer, James N, Kohanski, Michael A, Herbert, De'Broski R, and Cohen, Noam A
- Subjects
Nasal Mucosa ,Humans ,Fungi ,Alternaria ,Aspergillus fumigatus ,Sinusitis ,Rhinitis ,Interleukin-17 ,Allergens ,Antigens ,Fungal ,Chemoreceptor Cells ,Mycetoma ,IL-25 ,allergic fungal rhinosinusitis ,fungal antigens ,mycetoma ,solitary chemosensory cells ,type 2 inflammation ,Clinical Research ,Infectious Diseases ,Inflammatory and immune system ,Immunology - Abstract
BackgroundSolitary chemosensory cells (SCCs) are rare epithelial cells enriched in nasal polyps and are the primary source of interleukin-25 (IL-25), an innate cytokine eliciting T-helper 2 (Th2) immune response. Although it is proposed that SCCs are stimulated by antigens released by upper airway pathogens, the exogenous triggers of human SCCs remain elusive. We studied patients with noninvasive fungal rhinosinusitis to determine whether extracts of Aspergillus fumigatus and Alternaria alternata stimulate SCC proliferation as an early event in type 2 inflammation.MethodsMulticolor flow cytometry, immunofluorescence, and enzyme-linked immunoassay were used to interrogate mucosa from patients with mycetomas and allergic fungal rhinosinusitis (AFRS) for SCCs and IL-25. Primary sinonasal epithelial cells from AFRS patients and noninflamed inferior turbinates were stimulated with fungal extracts for 72 hours, and SCC population frequency as well as mitotic activity were quantified using flow cytometry.ResultsSCCs producing IL-25 are enriched in inflamed mucosa compared with intrapatient noninflamed control tissue (38.6% vs 6.5%, p = 0.029). In cultured sinonasal epithelial cells from AFRS nasal polyps, Aspergillus fumigatus and Alternaria alternata stimulated higher SCC frequency compared with controls (27.4% vs 10.6%, p = 0.002; 18.1% vs 10.6%, p = 0.046), which led to increased IL-25 secretion in culture media (75.5 vs 3.3 pg/mL, p < 0.001; 32.3 vs 3.3 pg/mL, p = 0.007). Ki-67 expression was higher in SCCs grown in fungal stimulation conditions compared with controls.ConclusionAlthough fungal antigens are known to potentiate immune response through innate cytokines, including IL-25, the early expansion of SCCs in the presence of fungus has not been described. This early event in the pathogenesis of noninvasive fungal rhinosinusitis may represent a target for intervention.
- Published
- 2019
12. Broncho‐Vaxom® (OM‐85 BV) soluble components stimulate sinonasal innate immunity
- Author
-
Triantafillou, Vasiliki, Workman, Alan D, Patel, Neil N, Maina, Ivy W, Tong, Charles CL, Kuan, Edward C, Kennedy, David W, Palmer, James N, Adappa, Nithin D, Waizel‐Haiat, Salomon, and Cohen, Noam A
- Subjects
Medical Physiology ,Biomedical and Clinical Sciences ,Infectious Diseases ,Lung ,Nutrition ,Good Health and Well Being ,Adjuvants ,Immunologic ,Cell Extracts ,Cells ,Cultured ,Cilia ,Epithelial Cells ,Humans ,Immunity ,Innate ,Nasal Mucosa ,Nitric Oxide ,sinusitis ,ciliary motility ,therapeutics ,immunotherapy ,innate immunity ,rhinosinusitis ,Immunology ,Clinical sciences - Abstract
BackgroundBroncho-Vaxom® (OM-85 BV) is an extract of infectious respiratory bacteria that is used as an immunostimulant outside of the United States for the prevention and treatment of bronchitis and rhinosinusitis. Prior studies have shown that use of OM-85 BV is associated with reduction in frequency of respiratory infection and decreased duration of antibiotic usage. However, the effects of OM-85 BV on respiratory mucosal innate immunity are unknown.MethodsHuman sinonasal epithelial cells were grown at an air-liquid interface (ALI). Ciliary beat frequency (CBF) and nitric oxide (NO) production in response to stimulation with OM-85 BV was measured in vitro. Pharmacologic inhibitors of bitter taste receptor (T2R) signaling were used to determine if this pathway was taste-receptor-mediated.ResultsApical application of OM-85 BV resulted in an NO-mediated increase in CBF (p
- Published
- 2019
13. Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution Experience
- Author
-
Workman, Alan D, Brody, Robert M, Kuan, Edward C, Baranov, Esther, Brooks, Steven G, Alonso-Basanta, Michelle, Newman, Jason G, Rassekh, Christopher H, Chalian, Ara A, Chiu, Alexander G, Weinstein, Gregory S, Feldman, Michael D, Adappa, Nithin D, O'Malley, Bert W, and Palmer, James N
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Trials and Supportive Activities ,Clinical Research ,Cancer ,SNUC ,sinonasal undifferentiated carcinoma ,survival ,treatment paradigms ,prognosis ,Neurology & Neurosurgery ,Dentistry - Abstract
Objective Sinonasal undifferentiated carcinoma (SNUC) is an aggressive neoplasm, with conflicting existing literature regarding prognosis and treatment due to the rarity of disease. Characterization of optimal SNUC management is necessary for improved outcomes. Study Design Case series with planned data collection and analysis. Setting Hospital of the University of Pennsylvania and Pennsylvania Hospital. Participants Patients with pathologically confirmed SNUC treated within a 15-year period were identified, and records were obtained and evaluated for several demographic characteristics. Main Outcomes Measures Disease-specific survival from diagnosis was the primary endpoint, while disease recurrence was a secondary endpoint of the study. Results Twenty-seven patients with established SNUC were included in this cohort, with a median age of 55 years. Eighty-five percent of patients were surgically treated, and 85% of patients presented with stage IV disease. Two-year disease-specific survival was 66% and 5-year disease-specific survival was 46%. Ninety-six percent of patients received both chemotherapy and radiation as adjuvant treatment. Nodal disease at presentation and disease recurrence both significantly decreased patient survival ( p
- Published
- 2019
14. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes
- Author
-
Li, Yize, Renner, David M., Comar, Courtney E., Whelan, Jillian N., Reyes, Hanako M., Cardenas-Diaz, Fabian Leonardo, Truitt, Rachel, Tan, Li Hui, Dong, Beihua, Alysandratos, Konstantinos Dionysios, Huang, Jessie, Palmer, James N., Adappa, Nithin D., Kohanski, Michael A., Kotton, Darrell N., Silverman, Robert H., Yang, Wenli, Morrisey, Edward E., Cohen, Noam A., and Weiss, Susan R.
- Published
- 2021
15. Solitary chemosensory cells producing interleukin‐25 and group‐2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps
- Author
-
Patel, Neil N, Kohanski, Michael A, Maina, Ivy W, Triantafillou, Vasiliki, Workman, Alan D, Tong, Charles CL, Kuan, Edward C, Bosso, John V, Adappa, Nithin D, Palmer, James N, Herbert, De'Broski R, and Cohen, Noam A
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Clinical Research ,Inflammatory and immune system ,Respiratory ,type-2 inflammation ,mucosal immunity ,IL-25 ,IL-13 ,CRSwNP ,Clinical sciences - Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is commonly characterized by type-2 inflammation. It is established that group-2 innate lymphoid cells (ILC2s) are a subset of immune cells important in orchestrating mucosal type-2 response. IL-25 is an epithelial-derived cytokine that is a critical activator of ILC2s. Recent evidence demonstrates that specialized taster epithelial cells, such as solitary chemosensory cells (SCCs), may be producers of IL-25. To elucidate the relationship between SCCs and ILC2s in CRSwNP, we sought to quantify ILC2s and SCCs to determine if these cell types are enriched in nasal polyps compared to healthy sinonasal mucosa. We quantified SCCs and ILC2s using multicolor flow cytometry in nasal polyps and non-inflamed turbinate mucosa from seven patients and investigated the role of IL-13 and dexamethasone on SCC frequency using tissue explants of nasal polyps and turbinate mucosa. SCCs were found to be the primary source of IL-25. Nasal polyps demonstrated higher populations of SCCs (33.0% vs 5.6%, p < 0.001) and ILC2s (2.40% vs 0.19%, p = 0.008) compared to patient-matched nonpolypoid turbinates. In cultured polyp explants, exogenous IL-13 increased the proportion of epithelial SCCs (40.2% IL-13 condition vs 28.9% untreated, p = 0.012), and this effect was reversed by addition of dexamethasone (40.2% vs 8.9%, p < 0.0005). These data support SCC and ILC2 expansion as well as increased IL-25 production in nasal polyps and may represent early events in the pathogenesis of CRSwNP. IL-13 stimulates proliferation of SCC in a feed-forward loop, a process that is steroid-sensitive.
- Published
- 2018
16. Pediatric Pituitary Surgery
- Author
-
Madsen, Peter J., Lang, Shih-Shan, Adappa, Nithin D., Palmer, James N., and Storm, Phillip B.
- Published
- 2022
- Full Text
- View/download PDF
17. Akt activator SC79 stimulates antibacterial nitric oxide generation in human nasal epithelial cells in vitro.
- Author
-
Lee, Robert J., Adappa, Nithin D., and Palmer, James N.
- Published
- 2024
- Full Text
- View/download PDF
18. Endoscopic Repair of Anterior Skull Base Cerebrospinal Fluid Leaks is Successful in Frail Patients.
- Author
-
Eide, Jacob G., Kshirsagar, Rijul S., Wen, Chris, Qatanani, Anas, Harris, Jacob, Sellers, Lauren, Abello, Eric H., Douglas, Jennifer E., Palmer, James N., Adappa, Nithin D., and Kuan, Edward C.
- Abstract
Objective: Surgical frailty estimates a patient's ability to withstand the physiologic stress of an intervention. There is limited data regarding the impact of frailty on endoscopic cerebrospinal fluid (CSF) leak repair. Methods: Patients undergoing CSF leak repair at two tertiary academic skull base programs were retrospectively reviewed. Demographic, treatment, and postoperative outcomes data were recorded. Frailty was calculated using validated indices, including the American Society of Anesthesiologists (ASA) classification, Charlson Comorbidity Index (CCI), and the Modified 5‐Item Frailty Index (mFI‐5). Outcomes included 30‐day medical and surgical complications and readmission. Results: A total of 185 patients were included with 128 (69.2%) female patients and average age of 54 ± 14 years. The average body mass index was 34.6 ± 8.5. The most common identified etiology was idiopathic intracranial hypertension (IIH) in 64 patients (34.6%). A total of 125 patients (68%) underwent perioperative lumbar drain placement (primarily to measure intracranial pressures and diagnose IIH). Most patients were ASA class 3 (48.6%) with mean CCI 2.14 ± 2.23 and mFI‐5 0.97 ± 0.90. Three patients had postoperative CSF leaks, with an overall repair success rate of 98.4%. There was no association between increased frailty and 30‐day medical outcomes, surgical outcomes, or readmission (all p > 0.05). Conclusions: Endoscopic CSF leak repair in a frail population, including lumbar drain placement and bed rest, was not associated with an increased rate of complications. Previous data suggests increased complications in open craniotomy procedures in patients with significant comorbidities. This study suggests that the endoscopic approach to CSF leak repair is well tolerated in the frail population. Level of Evidence: IV Laryngoscope, 134:2713–2717, 2024 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Effects of Akt Activator SC79 on Human M0 Macrophage Phagocytosis and Cytokine Production.
- Author
-
Lee, Robert J., Adappa, Nithin D., and Palmer, James N.
- Subjects
BITTERNESS (Taste) ,PATTERN perception receptors ,PHAGOCYTOSIS ,SMALL molecules ,EPITHELIAL cells ,MACROPHAGES ,FLUORESCENT probes ,COMPLEMENT receptors - Abstract
Akt is an important kinase in metabolism. Akt also phosphorylates and activates endothelial and neuronal nitric oxide (NO) synthases (eNOS and nNOS, respectively) expressed in M0 (unpolarized) macrophages. We showed that e/nNOS NO production downstream of bitter taste receptors enhances macrophage phagocytosis. In airway epithelial cells, we also showed that the activation of Akt by a small molecule (SC79) enhances NO production and increases levels of nuclear Nrf2, which reduces IL-8 transcription during concomitant stimulation with Toll-like receptor (TLR) 5 agonist flagellin. We hypothesized that SC79's production of NO in macrophages might likewise enhance phagocytosis and reduce the transcription of some pro-inflammatory cytokines. Using live cell imaging of fluorescent biosensors and indicator dyes, we found that SC79 induces Akt activation, NO production, and downstream cGMP production in primary human M0 macrophages. This was accompanied by a reduction in IL-6, IL-8, and IL-12 production during concomitant stimulation with bacterial lipopolysaccharide, an agonist of pattern recognition receptors including TLR4. Pharmacological inhibitors suggested that this effect was dependent on Akt and Nrf2. Together, these data suggest that several macrophage immune pathways are regulated by SC79 via Akt. A small-molecule Akt activator may be useful in some infection settings, warranting future in vivo studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Utility of a LangChain and OpenAI GPT‐powered chatbot based on the international consensus statement on allergy and rhinology: Rhinosinusitis.
- Author
-
Workman, Alan D., Rathi, Vinay K., Lerner, David K., Palmer, James N., Adappa, Nithin D., and Cohen, Noam A.
- Published
- 2024
- Full Text
- View/download PDF
21. Ectopic Pituitary Adenomas Presenting as Sphenoid or Clival Lesions: Case Series and Management Recommendations
- Author
-
Tajudeen, Bobby A, Kuan, Edward C, Adappa, Nithin D, Han, Joseph K, Chandra, Rakesh K, Palmer, James N, Kennedy, David W, Wang, Marilene B, and Suh, Jeffrey D
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Prevention ,Neurosciences ,pituitary adenoma ,ectopic pituitary tumors ,sphenoid tumors ,clival tumors ,Neurology & Neurosurgery ,Dentistry - Abstract
Background An ectopic pituitary adenoma presenting as a clival or sphenoid mass is a rare clinical occurrence that may mislead the clinician and result in unnecessary interventions or potential medicolegal consequences. Here, we present one of the largest multi-institutional case series and review the literature with an emphasis on radiological findings and critical preoperative workup. Methods Retrospective chart review. Results Nine patients were identified with ectopic pituitary adenomas of the sphenoid or clivus. There were four females and five males. Median age was 60 years old (range, 36-73 years). The most common presenting symptom was headache (56%). Five (56%) patients presented with a mass arising from the clivus while four (44%) presented with a mass in the sphenoid. Six (67%) patients demonstrated biochemical evidence of hypersecretion on full endocrinology panel. All masses showed evidence of enhancement with gadolinium with a propensity for adjacent bone involvement. Lesions also had a predilection for growth toward the cavernous sinus, carotid artery, or sellar floor. Surgical intervention was performed in eight patients (89%). In eight patients (89%), tumors demonstrated immunoreactivity to prolactin. Conclusions Pituitary adenomas can rarely present as an isolated sphenoid or clival mass. Lesions displayed similar magnetic resonance imaging findings with an erosive growth pattern toward the sellar floor, cavernous sinus, or adjacent carotid artery. Patients with clival or parasellar lesions with comparable features should have a preoperative workup which includes prolactin level and alert the physician to consider an ectopic pituitary adenoma in the differential to prevent unnecessary surgery and potential complications.
- Published
- 2017
22. Quality-of-life improvement after endoscopic sinus surgery in patients with obstructive sleep apnea.
- Author
-
Tajudeen, Bobby A, Brooks, Steven G, Yan, Carol H, Kuan, Edward C, Schwartz, Joseph S, Suh, Jeffrey D, Palmer, James N, and Adappa, Nithin D
- Subjects
Lung ,Sleep Research ,Clinical Research ,Respiratory - Abstract
BackgroundThere is preliminary evidence that patients with chronic rhinosinusitis (CRS) and comorbid obstructive sleep apnea (OSA) have reduced quality-of-life (QOL) improvements after functional endoscopic sinus surgery (FESS) compared with patients without OSA. The effect of OSA severity on QOL improvement after FESS is unknown.ObjectivesTo better characterize the QOL improvement after FESS for patients with comorbid OSA and to assess whether QOL improvement is dependent on OSA severity.MethodsThis multi-institution, retrospective cohort study evaluated adult patients with CRS who underwent FESS between 2007 and 2015. Preoperative, 1-month, 3-month, 6-month, and 1-year postoperative 22-Item Sino-Nasal Outcome Test scores were used to evaluate QOL. We compared patients without OSA with patients with stratified OSA based on the preoperative apnea-hypopnea index. A multilevel, mixed-effects linear regression model was used for the analysis.ResultsOf 480 participants, 83 (17%) had OSA, and 47 of these patients had polysomnography results available for review. Both patients with OSA and patients without OSA reported significant QOL improvement after surgery (p < 0.0001) relative to baseline. In the unadjusted model, the subjects with OSA demonstrated a statistically worse outcome in 22-Item Sino-Nasal Outcome Test scores at each time point (2.4 points higher per time point, p = 0.006). When controlling for covariates, the adjusted model showed no difference in QOL outcome based on OSA status (p = 0.114). When stratified by OSA disease severity, the adjusted model showed no difference in the QOL outcome.ConclusionsPatients with CRS and comorbid OSA had worse QOL outcomes after FESS; however, when controlling for patient factors, there was no difference in QOL outcome. OSA disease severity did not seem to predict QOL improvement after FESS.
- Published
- 2017
23. Extraprimary Local Recurrence of Esthesioneuroblastoma: Case Series and Literature Review
- Author
-
Maina, Ivy W., Lehrich, Brandon M., Goshtasbi, Khodayar, Su, Brooke M., Stubbs, Vanessa C., Tong, Charles C.L., Kohanski, Michael A., Lee, John Y.K., Luu, Quang C., Newman, Jason G., Palmer, James N., Adappa, Nithin D., and Kuan, Edward C.
- Published
- 2020
- Full Text
- View/download PDF
24. Personalized Approach to Olfactory Neuroblastoma Care.
- Author
-
Lerner, David K. and Palmer, James N.
- Subjects
- *
SURGICAL margin , *NEUROBLASTOMA , *ENDOSCOPIC surgery , *MAGNETIC resonance imaging , *SURGICAL excision , *NECK dissection - Abstract
Olfactory neuroblastoma (ONB) is an uncommon neuroendocrine malignancy arising from the olfactory neuroepithelium. ONB frequently presents with nonspecific sinonasal complaints, including nasal obstruction and epistaxis, and diagnosis can be obtained through a combination of physical examination, nasal endoscopy, and computed tomography and magnetic resonance imaging. Endoscopic resection with negative margins, with or without craniotomy, as necessary, is the standard of care for definitive treatment of ONB. Regional metastasis to the neck is often detected at presentation or may occur in a delayed fashion and should be addressed through elective neck dissection or radiation. Adjuvant radiotherapy should be considered, particularly in the case of high grade or tumor stage, as well as positive surgical margins. Systemic therapy is an area of active investigation in both the neoadjuvant and adjuvant setting, with many advocating in favor of induction chemotherapy for significant orbital or intracranial involvement prior to surgical resection. Various targeted immunotherapies are currently being studied for the treatment of recurrent or metastatic ONB. Prolonged locoregional and distant surveillance are indicated following definitive treatment, given the tendency for delayed recurrence and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Secondary Repair of Iatrogenic Cerebrospinal Fluid Leak during Functional Endoscopic Sinus Surgery in a Tertiary-Care Center.
- Author
-
Lerner, David K., Chesnais, Helene, Workman, Alan D., Douglas, Jennifer E., Kohanski, Michael A., Palmer, James N., and Adappa, Nithin D.
- Subjects
RHINORRHEA ,CEREBROSPINAL fluid leak ,ENDOSCOPIC surgery ,ALLERGIC fungal sinusitis ,IATROGENIC diseases - Abstract
This article discusses the secondary repair of iatrogenic cerebrospinal fluid (CSF) leaks during functional endoscopic sinus surgery (FESS) in a tertiary-care center. The study included 12 patients who underwent secondary repair of CSF leaks. The average time from initial surgery to presentation at the institution was 8.25 days, and CSF leaks were recognized intraoperatively in 33.3% of cases. The management included updated CT scans, intravenous ceftriaxone, and operative repair tailored to each patient. Acetazolamide was started postoperatively for patients with a BMI greater than 40, and there were no cases of persistent CSF leaks or meningitis. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
26. Endoscopic Endonasal Approach to Anterior Skull Base Tumor Resection in Young Children.
- Author
-
Lerner, David K., Castellanos, Mackenzie, Workman, Alan D., Kohanski, Michael A., Douglas, Jennifer E., Storm, Phillip B., Palmer, James N., and Adappa, Nithin D.
- Subjects
TUMOR surgery ,SKULL base ,SKULL tumors ,CHILD patients - Abstract
This article discusses the use of an endoscopic endonasal approach (EEA) for the resection of anterior skull base tumors in young children. Traditionally, these tumors have been treated with open craniotomy, but the EEA has become more common in pediatric patients. The article reviews a retrospective study of ten patients aged 5 or younger who underwent EEA for tumor resection. The results showed that the EEA was safe and effective, with successful reconstruction of the skull base in all cases. Further research is needed to evaluate the EEA in this population. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
27. Frailty Does Not Impact Postoperative Outcomes in Extended Endonasal Approaches for Olfactory Groove Meningiomas Compared with Open Craniotomy.
- Author
-
Ajmera, Sonia, Gandhi, Om H., Blue, Rachel, Douglas, Jennifer, Jackson, Christina, Adappa, Nithin, Palmer, James N., Jabarkheel, Rashad, and Lee, John Y.
- Subjects
RHINORRHEA ,TREATMENT effectiveness ,FRAILTY ,CRANIOTOMY ,CEREBROSPINAL fluid leak - Abstract
This article examines the impact of frailty on postoperative outcomes in patients undergoing open and endoscopic resection of olfactory groove meningiomas. The study included 19 patients, with 6 undergoing endoscopic resection and 13 undergoing open craniotomy. The results showed that frailty metrics, such as the Charlson Comorbidity Index and modified 5-item frailty index, were not associated with postoperative complications or poor neurologic outcomes. However, a prior history of cranial radiation was associated with complications in open cases. The study suggests a need to reconsider traditional frailty measures in these surgical procedures. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
28. Impact of Patient Demographics and Socioeconomic Status on Surgical Outcomes in Endonasal Endoscopic Pituitary Surgery.
- Author
-
Blue, Rachel, Miranda, Stephen P., Ajmera, Sonia, Kumar, Nankee, Alexis, Maya, Heman-Ackah, Sabrina, Salwi, Sanjana, Palmer, James N., Adappa, Nithin D., Lee, John Y.K., Grady, M. Sean, Yoshor, Daniel, and Jackson, Christina
- Subjects
ENDOSCOPIC surgery ,SOCIOECONOMIC status ,INCOME - Abstract
This article explores the impact of patient demographics and socioeconomic status on surgical outcomes in endonasal endoscopic pituitary surgery. The study reviewed 187 patients who underwent this surgery between 2017 and 2019. The findings revealed that male patients were more likely to have larger tumors and higher comorbidity scores, while Hispanic patients had smaller tumors and lower comorbidity scores. Black patients experienced longer hospital stays, higher costs, and higher rates of readmission, regardless of income. These results suggest that racial health disparities are not solely due to socioeconomic status and emphasize the importance of considering social determinants of health in clinical practice. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
29. Impact of Frailty on Postoperative Outcomes in Extended Endonasal Skull Base Surgery for Suprasellar Pathologies.
- Author
-
Kshirsagar, Rijul S., Eide, Jacob G., Qatanani, Anas, Harris, Jacob, Abello, Eric H., Roman, Kelsey M., Vasudev, Milind, Jackson, Christina, Lee, John Y.K., Kuan, Edward C., Palmer, James N., and Adappa, Nithin D.
- Abstract
Objective: Frailty metrics estimate a patient's ability to tolerate physiologic stress and there are limited frailty data in patients undergoing expanded endonasal approaches (EEA) for suprasellar pathologies. Elevated frailty metrics have been associated with increased perioperative complications in patients undergoing craniotomies. We sought to examine this potential relationship in EEA. Study Design: Retrospective cohort study. Setting: Two tertiary academic skull base centers. Methods: Cases of patients undergoing EEA for suprasellar pathologies were reviewed. Demographic, treatment, survival, and postoperative outcomes data were recorded. Frailty was calculated using validated indexes, including the American Society of Anesthesiologists (ASA) classification, the modified 5‐item frailty index (mFI‐5), and the Charlson comorbidity index (CCI). Primary outcomes included 30‐day medical and surgical complications. Results: A total of 88 patients were included, with 59 (67%) female patients and a mean age of 54 ± 15 years. The most common pathologies included 53 meningiomas (60.2%) and 21 craniopharyngiomas (23.9%). Most patients were ASA class 3 (54.5%) with mean mFI‐5 0.82 ± 1.01 and CCI 4.18 ± 2.42. There was no association between increased frailty and 30‐day medical or surgical outcomes (including postoperative cerebrospinal fluid leak), prolonged length of hospital stay, or mortality (all P >.05). Higher mFI‐5 was associated with an increased risk for 30‐day readmission (odds ratio: 2.35, 95% confidence Interval: 1.10‐5.64, P =.04). Conclusion: Despite the patient population being notably frail, we only identified an increased risk for 30‐day readmission and observed no links with deteriorating surgical, medical, or mortality outcomes. This implies that conventional frailty metrics may not effectively align with EEA outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Effects of BNO 1016 on ciliary transport velocity and cell culture surface liquid height of sinonasal epithelial cultures
- Author
-
Workman, Alan D., Maina, Ivy W., Triantafillou, Vasiliki, Patel, Neil N., Tong, Charles C. L., Kuan, Edward C., Kennedy, David W., Palmer, James N., Adappa, Nithin D., and Cohen, Noam A.
- Published
- 2021
- Full Text
- View/download PDF
31. Bitter taste receptor agonists regulate epithelial two-pore potassium channels via cAMP signaling
- Author
-
Kohanski, Michael A., Brown, Lauren, Orr, Melissa, Tan, Li Hui, Adappa, Nithin D., Palmer, James N., Rubenstein, Ronald C., and Cohen, Noam A.
- Published
- 2021
- Full Text
- View/download PDF
32. Small-molecule Akt-activation in airway cells induces NO production and reduces IL-8 transcription through Nrf-2
- Author
-
Gopallawa, Indiwari, Kuek, Li Eon, Adappa, Nithin D., Palmer, James N., and Lee, Robert J.
- Published
- 2021
- Full Text
- View/download PDF
33. Combined Transnasal, Transoral Excision of Odontogenic Cysts Offers Reduced Recurrence Rates and Favorable Sinonasal Outcomes.
- Author
-
Douglas, Jennifer E., Wei, Kimberly, Panara, Kush, Lee, Daniel J., Kohanski, Michael A., Shanti, Rabie M., Panchal, Neeraj, Palmer, James N., and Adappa, Nithin D.
- Abstract
A study published in the journal Laryngoscope discusses the use of a combined transnasal, transoral approach for the removal of odontogenic cysts. The study found that this approach resulted in reduced recurrence rates and favorable sinonasal outcomes compared to traditional transoral-only approaches. The study included a retrospective review of patients who underwent the combined approach and collected data on demographic information, clinical history, and sinonasal outcomes. The results showed a low recurrence rate and improvement in sinonasal symptoms. The study recommends considering this approach for the management of odontogenic cysts involving the maxillary sinus. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
34. Special considerations for nasoseptal flap use in children
- Author
-
Kuan, Edward C., Carey, Ryan M., Palmer, James N., and Adappa, Nithin D.
- Published
- 2019
- Full Text
- View/download PDF
35. Endoscopic transsphenoidal pituitary surgery in children
- Author
-
Kuan, Edward C., Storm, Phillip B., Palmer, James N., and Adappa, Nithin D.
- Published
- 2019
- Full Text
- View/download PDF
36. Multi‐institutional Analysis of Endoscopic Sellar Surgical Volumes During the COVID‐19 Pandemic.
- Author
-
Salmon, Mandy K., Eide, Jacob G., Kshirsagar, Rijul S., Blue, Rachel, Yoshor, Daniel, Sean Grady, Michael, Lee, John Y.K., Palmer, James N., and Adappa, Nithin D.
- Abstract
Objective: We sought to quantify trends in operative volumes and complications of endoscopic sellar surgery before and after the COVID‐19 pandemic onset. Study Design: We performed a retrospective analysis. Setting: TriNetX database analysis. Methods: All adults undergoing neuroendoscopy for resection of pituitary tumor (Current Procedural Terminology code 62165) with diagnosis of benign/malignant neoplasm of pituitary gland (D35.2/C75.1) or benign/malignant neoplasm of craniopharyngeal duct (D35.3/C75.2) were included using the TriNetX database for 2 years before (pre‐COVID group) and 2 years after (post‐COVID group) February 17, 2020. Results: A total of 1238 patients in the pre‐COVID group and 1186 patients in the post‐COVID group were compared. Age, gender, and race were statistically similar between the groups (P >.05). Surgical volume decreased by 6% in the post‐COVID group. In 2020 Q2, operative volume decreased by 19%, and in 2021 Q4 (peak COVID‐19 caseload in the United States), operative volumes decreased by 29% compared to 2 years prior. Postoperative complications including meningitis (P =.49), cerebrospinal fluid leak (P =.36), visual field deficits (P =.07), postoperative pneumonia or respiratory failure (P =.42), and 30‐day readmission rates (P =.89) were similar between the 2 groups. Conclusion: Overall, endoscopic sellar surgery may continue to fluctuate with increased COVID‐19 outbreaks. Patient outcomes do not appear to be worsened by decreased operative volumes or delays in nonurgent surgeries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. The use of aprepitant for the prevention of postoperative nausea and vomiting in endoscopic transsphenoidal pituitary surgery.
- Author
-
Lee, Daniel J., Douglas, Jennifer E., Chang, Jeremy, Wilensky, Jadyn, Jackson, Christina, Lee, John Y. K., Grady, Michael Sean, Yoshor, Daniel, Kohanski, Michael A., Palmer, James N., Atkins, Joshua H., and Adappa, Nithin D.
- Published
- 2023
- Full Text
- View/download PDF
38. Recurrence patterns among patients with sinonasal mucosal melanoma: A multi‐institutional study.
- Author
-
Pandrangi, Vivek C., Mace, Jess C., Abiri, Arash, Adappa, Nithin D., Beswick, Daniel M., Chang, Eugene H., Eide, Jacob G., Fung, Nicholas, Hong, Michelle, Johnson, Brian J., Kohanski, Michael A., Kshirsagar, Rijul S., Kuan, Edward C., Le, Christopher H., Lee, Jivianne T., Nabavizadeh, Seyed A., Obermeyer, Isaac P., Palmer, James N., Pinheiro‐Neto, Carlos D., and Smith, Timothy L.
- Published
- 2023
- Full Text
- View/download PDF
39. A metagenomic analysis of the virome of inverted papilloma and squamous cell carcinoma.
- Author
-
Tong, Charles C. L., Lin, Xiang, Seckar, Tyler, Koptyra, Mateusz, Kohanski, Michael A., Cohen, Noam A., Kennedy, David W., Adappa, Nithin D., Papagiannopoulos, Peter, Kuan, Edward C., Baranov, Esther, Jalaly, Jalal B., Feldman, Michael D., Storm, Phillip B., Resnick, Adam C., Palmer, James N., Wei, Zhi, and Robertson, Erle S.
- Published
- 2023
- Full Text
- View/download PDF
40. Updates in the cause of sinonasal inverted papilloma and malignant transformation to squamous cell carcinoma
- Author
-
Tong, Charles C.L. and Palmer, James N.
- Published
- 2021
- Full Text
- View/download PDF
41. Long‐term aspirin desensitization has mucosal cytokine features of immune tolerance.
- Author
-
Kohanski, Michael A., Qatanani, Anas, Lin, Cailu, Tan, Li Hui, Chang, Jeremy, Corr, Andrew, Herzberg, Sabrina, Adappa, Nithin D., Palmer, James N., Reed, Danielle R., Bosso, John V., and Cohen, Noam A.
- Subjects
IMMUNOLOGICAL tolerance ,ALLERGY desensitization ,NASAL polyps ,ASPIRIN ,CYTOKINES ,TH2 cells ,TUMOR necrosis factors - Abstract
This article discusses the long-term effects of aspirin desensitization on the inflammatory response in patients with aspirin-exacerbated respiratory disease (AERD). The study found that after long-term aspirin desensitization, there were significant increases in interferon-gamma (IFN-γ) and interleukin-10 (IL-10), suggesting a shift in the inflammatory response. These cytokines are associated with immune tolerance and may play a role in the mechanism of aspirin desensitization. However, the specific cells producing these cytokines and the role of lipid mediators in aspirin desensitization were not addressed in this study. Further research is needed to understand the cellular context and mechanisms associated with these cytokine shifts. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
42. Clinical Consensus Statement
- Author
-
Setzen, Gavin, Ferguson, Berrylin J, Han, Joseph K, Rhee, John S, Cornelius, Rebecca S, Froum, Stuart J, Gillman, Grant S, Houser, Steven M, Krakovitz, Paul R, Monfared, Ashkan, Palmer, James N, Rosbe, Kristina W, Setzen, Michael, and Patel, Milesh M
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biomedical Imaging ,Pediatric ,Clinical Research ,Humans ,Paranasal Sinus Diseases ,Tomography ,X-Ray Computed ,consensus statement ,computed tomography ,paranasal sinus disease ,sinusitis ,adults ,children ,Otorhinolaryngology ,Clinical sciences - Abstract
ObjectiveTo develop a consensus statement on the appropriate use of computed tomography (CT) for paranasal sinus disease.Subjects and methodsA modified Delphi method was used to refine expert opinion and reach consensus by the panel.ResultsAfter 3 full Delphi rounds, 33 items reached consensus and 16 statements were dropped because of not reaching consensus or redundancy. The statements that reached consensus were grouped into 4 categories: pediatric sinusitis, medical management, surgical planning, and complication of sinusitis or sinonasal tumor. The panel unanimously agreed with 13 of the 33 statements. In addition, at least 75% of the panel strongly agreed with 14 of 33 statements across all of the categories.ConclusionsFor children, careful consideration should be taken when performing CT imaging but is needed in the setting of treatment failures and complications, either of the pathological process itself or as a result of iatrogenic (surgical) complications. For adults, imaging is necessary in surgical planning, for treatment of medical and surgical complications, and in all aspects of the complete management of patients with sinonasal and skull base pathology.
- Published
- 2012
43. Clinical consensus statement: appropriate use of computed tomography for paranasal sinus disease.
- Author
-
Setzen, Gavin, Ferguson, Berrylin J, Han, Joseph K, Rhee, John S, Cornelius, Rebecca S, Froum, Stuart J, Gillman, Grant S, Houser, Steven M, Krakovitz, Paul R, Monfared, Ashkan, Palmer, James N, Rosbe, Kristina W, Setzen, Michael, and Patel, Milesh M
- Subjects
Humans ,Paranasal Sinus Diseases ,Tomography ,X-Ray Computed ,consensus statement ,computed tomography ,paranasal sinus disease ,sinusitis ,adults ,children ,Tomography ,X-Ray Computed ,Otorhinolaryngology ,Clinical Sciences - Abstract
ObjectiveTo develop a consensus statement on the appropriate use of computed tomography (CT) for paranasal sinus disease.Subjects and methodsA modified Delphi method was used to refine expert opinion and reach consensus by the panel.ResultsAfter 3 full Delphi rounds, 33 items reached consensus and 16 statements were dropped because of not reaching consensus or redundancy. The statements that reached consensus were grouped into 4 categories: pediatric sinusitis, medical management, surgical planning, and complication of sinusitis or sinonasal tumor. The panel unanimously agreed with 13 of the 33 statements. In addition, at least 75% of the panel strongly agreed with 14 of 33 statements across all of the categories.ConclusionsFor children, careful consideration should be taken when performing CT imaging but is needed in the setting of treatment failures and complications, either of the pathological process itself or as a result of iatrogenic (surgical) complications. For adults, imaging is necessary in surgical planning, for treatment of medical and surgical complications, and in all aspects of the complete management of patients with sinonasal and skull base pathology.
- Published
- 2012
44. The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis.
- Author
-
Lee, Daniel J., Grose, Elysia, Brenna, Connor T. A., Philteos, Justine, Lightfoot, David, Kirubalingam, Keshinisuthan, Chan, Yvonne, Palmer, James N., Adappa, Nithin D., and Lee, John M.
- Published
- 2023
- Full Text
- View/download PDF
45. The Impact of Delay in Treatment on Survival in Surgically Managed Sinonasal Undifferentiated Carcinoma.
- Author
-
Qatanani, Anas M., Eide, Jacob G., Harris, Jacob C., Brant, Jason A., Palmer, James N., Adappa, Nithin D., and Kshirsagar, Rijul S.
- Subjects
TREATMENT delay (Medicine) ,CARCINOMA ,PARANASAL sinuses ,RECURSIVE partitioning ,GOVERNMENT insurance ,SURVIVAL analysis (Biometry) ,PROGRESSION-free survival - Abstract
Background Sinonasal undifferentiated carcinoma (SNUC) is a rare, aggressive malignancy with a poor prognosis, and multimodal therapy is the standard of care. We sought to characterize treatment delays in SNUC managed with surgery and adjuvant radiation and to determine the impact on survival using the National Cancer Database (NCDB). Methods This was a retrospective, population-based cohort study of patients with SNUC between 2004 and 2016 in the NCDB. The intervals of diagnosis to surgery (DTS), surgery to radiation (SRT), and radiation duration (RTD) were examined. Recursive partitioning analysis (RPA) was performed to identify the variables with the greatest impact on survival. The association between treatment delay and overall survival (OS) was then assessed using multivariate Cox proportional hazards regression. Results Of 173 patients who met inclusion criteria, 65.9% were male, average age at diagnosis was 56.6 years, and 5-year OS was 48.1%. Median durations of DTS, SRT, and RTD were 18, 43, and 46 days, respectively. Predictors of treatment delay included Black race, government insurance excluding Medicare/Medicaid, and positive margins. RPA-derived optimal thresholds were 29, 28, and 38 days for DTS, SRT and RTD, respectively. On multivariate analysis, positive margins (hazard ratio [HR]: 4.82; 95% confidence interval [CI]: 2.28–10.2) and DTS less than 29 days (HR: 2.41; 95% CI: 1.23–4.73) were associated with worse OS. Conclusion Our results likely reflect the aggressive nature of the disease with surgeons taking more invasive disease to the operating room more quickly. Median treatment intervals described may serve as relevant national benchmarks. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Incidence of Sinus Inflammation After Endoscopic Skull Base Surgery in the Pediatric Population.
- Author
-
Henry, Laura E., Eide, Jacob G., Kshirsagar, Rijul S., Tong, Charles C. L., Kuan, Edward C., Poonia, Seerat K., Storm, Phillip B., Palmer, James N., and Adappa, Nithin D.
- Abstract
Background: The extended endonasal approach has been utilized in the resection of anterior skull base lesions in the pediatric population. There are unique challenges to these patients in the post‐operative setting, including patient compliance with medical therapy and post‐operative debridements, and a smaller nasal airway that may increase propensity toward scarring. Our objective for this study is to evaluate the incidence of post‐operative radiographic inflammation in this patient population using the Lund‐Mackay (LM) score. Methods: A single‐center, retrospective review of pediatric patients undergoing endoscopic approach to the skull base between 2009 and 2021 was performed. Demographic and clinicopathologic data and pre‐ and post‐operative imaging were analyzed. One‐way ANOVA followed by Tukey multiple pairwise comparisons statistical tests were used to compare mean LM scores between groups. Results: Seventy‐two patients (52 males, 20 females) were identified with a median follow‐up of 27 months. All patients underwent an extended endonasal approach for resection of skull base lesions. The mean LM scores were compared between pre‐operative MRI, first post‐operative MRI > 30 days after surgery, and most recent post‐operative MRI. One‐way ANOVA was performed with significant differences noted between the groups (p < 0.001). Tukey multiple pairwise comparisons test was then performed and noted significant differences between the pre‐operative and first post‐operative LM (p < 0.0001) and the first post‐operative and most recent LM (p < 0.0001). There was no significant difference noted between the pre‐operative LM score and most recent LM score (p = 0.14). Conclusion: Despite concerns regarding possible subsequent development of chronic rhinosinusitis following endoscopic skull base surgery in pediatric patients, the current study suggests that transient radiographic evidence of sinus inflammation can be seen up to six months postoperatively, which appears to resolve by approximately two years after surgery. Level of Evidence: 4 Laryngoscope, 133:2014–2017, 2023 [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Dupilumab‐related adverse events among patients with chronic rhinosinusitis with nasal polyposis.
- Author
-
Lee, Daniel J., Cramer, Hannah B., Kshirsagar, Rijul S., Douglas, Jennifer E., Kohanski, Michael A., Palmer, James N., Adappa, Nithin D., and Bosso, John V.
- Published
- 2023
- Full Text
- View/download PDF
48. Microbial metabolite succinate activates solitary chemosensory cells in the human sinonasal epithelium.
- Author
-
Sell, Elizabeth A., Tan, Li Hui, Lin, Cailu, Bosso, John V., Palmer, James N., Adappa, Nithin D., Lee, Robert J., Kohanski, Michael A., Reed, Danielle R., and Cohen, Noam A.
- Published
- 2023
- Full Text
- View/download PDF
49. Primary sinonasal lymphoma: A multi‐institutional experience of clinical presentation, treatment, and outcomes.
- Author
-
Eide, Jacob G., Kshirsagar, Rijul S., Birkenbeuel, Jack L., Abello, Eric H., Hobday, Sara, Herzberg, Sabrina, Wang, Beverly Y., Palmer, James N., Adappa, Nithin D., and Kuan, Edward C.
- Published
- 2023
- Full Text
- View/download PDF
50. Readability and quality analysis of patient education materials in aspirin‐exacerbated respiratory disease.
- Author
-
Panara, Kush, Grose, Elysia, Lee, Daniel J., Safadi, Jenelle, Douglas, Jennifer E., Kohanski, Michael A., Palmer, James N., Lee, John M., Adappa, Nithin D., and Bosso, John V.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.